The estimated Net Worth of Uri Weinberg is at least $2.76 million dollars as of 5 January 2023. Mr Weinberg owns over 8,143 units of NovoCure Ltd stock worth over $745,818 and over the last 5 years he sold NVCR stock worth over $2,017,251.
Mr has made over 6 trades of the NovoCure Ltd stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 8,143 units of NVCR stock worth $945,728 on 5 January 2023.
The largest trade he's ever made was exercising 15,250 units of NovoCure Ltd stock on 25 September 2020 worth over $146,705. On average, Mr trades about 2,402 units every 57 days since 2020. As of 5 January 2023 he still owns at least 43,286 units of NovoCure Ltd stock.
You can see the complete history of Mr Weinberg stock trades at the bottom of the page.
Uri Weinberg M.D., Ph.D. is the Chief Science Officer at NovoCure Ltd.
Uri's mailing address filed with the SEC is C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE, PA, 19087.
Over the last 9 years, insiders at NovoCure Ltd have traded over $237,132,855 worth of NovoCure Ltd stock and bought 164,174 units worth $2,198,429 . The most active insiders traders include Asaf Danziger, William Fwfd Ventures Fund ... et Michael J. Ambrogi. On average, NovoCure Ltd executives and independent directors trade stock every 7 days with the average trade being worth of $853,350. The most recent stock trade was executed by Ashley Cordova on 2 August 2024, trading 688 units of NVCR stock currently worth $13,856.
we are a commercial-stage oncology company developing a novel, proprietary therapy called tumor treating fields, or ttfields, for the treatment of solid tumor cancers. we count on the contributions of our talented team members who are committed to improving the lives of cancer patients. here at novocure, cancer patients and their families are – and have always been – at the core of our mission. we expect our colleagues to excel, and in return, we invest in their professional growth and personal well-being. we seek high performers who thrive in fast-paced environments and are inspired by making a difference in cancer care. we offer employment opportunities in the u.s., europe and asia.
NovoCure Ltd executives and other stock owners filed with the SEC include: